Log In
person
Insmed Inc
INSM
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Therapies for Rare Diseases |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
305.21M | 100.00% |
| Therapies for Rare Diseases |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Therapies for Rare Diseases
Branded Pharmaceuticals
|
305.21M | 100.00% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Therapies for Rare Diseases
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||